Inj. remestemcel-l-rknd/ td
Products billed under this code include Ryoncil.
Payment limit per Per Therapeutic Dose, by effective quarter, 4Q25 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Ryoncil.
Payment limit per Per Therapeutic Dose, by effective quarter, 4Q25 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Ryoncil | Mesoblast, Inc. | 73648-0111-01 | 1 | $202,159.938 |
| Ryoncil | Mesoblast, Inc. | 73648-0112-02 | 1 | $202,159.938 |
| Ryoncil | Mesoblast, Inc. | 73648-0113-03 | 1 | $202,159.938 |
| Ryoncil | Mesoblast, Inc. | 73648-0114-01 | 1 | $202,159.938 |
| Ryoncil | Mesoblast, Inc. | 73648-0115-02 | 1 | $202,159.938 |
| Ryoncil | Mesoblast, Inc. | 73648-0116-03 | 1 | $202,159.938 |
| Ryoncil | Mesoblast, Inc. | 73648-0117-04 | 1 | $202,159.938 |
| Ryoncil | Mesoblast, Inc. | 73648-0118-02 | 1 | $202,159.938 |
| Ryoncil | Mesoblast, Inc. | 73648-0122-03 | 1 | $202,159.938 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $202,159.938 | −$1,499.825 | Per Therapeutic Dose | Inj. remestemcel-l-rknd/ td | v1, posted September 17, 2026 |
| 3Q26 | $203,659.763 | +$946.179 | Per Therapeutic Dose | Inj. remestemcel-l-rknd/ td | v1, posted September 15, 2026 |
| 2Q26 | $202,713.584 | +$1,044.563 | Per Therapeutic Dose | Inj. remestemcel-l-rknd/ td | v1, posted September 15, 2026 |
| 1Q26 | $201,669.021 | −$3,970.979 | Per Therapeutic Dose | Inj. remestemcel-l-rknd/ td | v1, posted September 15, 2026 |
| 4Q25 | $205,640.00 | – | Per Therapeutic Dose | Inj. remestemcel-l-rknd/ td | v1, posted September 8, 2026 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.